BRAF inhibitors together with MEK inhibitors could induce pyroptosis in melanoma with a higher HMGB1, more tumor-associated T cells, and less dendritic cell infiltration, while GSDME deficiency would reverse the anti-tumor immunity [91] (Table 2 and Table 3). This evidence concerns the gene BRAF and neoplasm.